36 Publications (Page 1 of 2)
2016
Bladder cancer
Kamat, Ashish⋅Hahn, Noah⋅Efstathiou, Jason⋅Lerner, Seth⋅Malmström, Per-Uno⋅Choi, Woonyoung⋅Guo, Charles⋅Lotan, Yair and Kassouf, Wassim
The Lancet, vol. 388, (no. 10061), pp. 2796-2810, Dec 3, 2016. | Journal Article
 
Bladder cancer.
Kamat, Ashish M⋅Hahn, Noah M⋅Efstathiou, Jason A⋅Lerner, Seth P⋅Malmström, Per-Uno⋅Choi, Woonyoung⋅Guo, Charles C⋅Lotan, Yair and Kassouf, Wassim
Lancet (London, England), June 23, 2016. | Journal Article
2014
Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer.
Galsky, Matthew⋅Krege, Susan⋅Lin, Chia-Chi⋅Hahn, Noah⋅Ecke, Thorsten H⋅Moshier, Erin⋅Sonpavde, Guru⋅Godbold, James⋅Oh, William K and Bamias, Aristotle
Urologic oncology, vol. 32, (no. 1), pp. 30.e15-21, 2014/Jan. | Journal Article
 
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder.
Alexander, Riley E⋅Alexander, Riley E⋅Alexander, Riley E⋅Alexander, Riley E⋅Montironi, Rodolfo⋅Montironi, Rodolfo⋅Montironi, Rodolfo⋅Montironi, Rodolfo⋅Lopez-Beltran, Antonio⋅Lopez-Beltran, Antonio⋅Lopez-Beltran, Antonio⋅Lopez-Beltran, Antonio⋅Williamson, Sean R⋅Williamson, Sean R⋅Williamson, Sean R⋅Williamson, Sean R⋅Wang, Mingsheng⋅Wang, Mingsheng⋅Wang, Mingsheng⋅Wang, Mingsheng⋅Post, Kristin M⋅Post, Kristin M⋅Post, Kristin M⋅Post, Kristin M⋅Sen, Joyashree D⋅Sen, Joyashree D⋅Sen, Joyashree D⋅Sen, Joyashree D⋅Arnold, Ashley K⋅Arnold, Ashley K⋅Arnold, Ashley K⋅Arnold, Ashley K⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Wang, Xiaoyan⋅Wang, Xiaoyan⋅Wang, Xiaoyan⋅Wang, Xiaoyan⋅Koch, Michael O⋅Koch, Michael O⋅Koch, Michael O⋅Koch, Michael O⋅Hahn, Noah M⋅Hahn, Noah M⋅Hahn, Noah M⋅Hahn, Noah⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Mac Lennan, Gregory⋅MacLennan, Gregory T⋅MacLennan, Gregory T⋅MacLennan, Gregory T⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Compérat, Eva⋅Compérat, Eva⋅Compérat, Eva⋅Compérat, Eva⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang and Cheng, Liang
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol. 27, (no. 1), pp. 107-12, 2014/Jan. | Journal Article
 
Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event.
Hahn, Noah⋅Yiannoutsos, Constantin T⋅Kirkpatrick, Kristina⋅Sharma, Jaya and Sweeney, Christopher J
Clinical genitourinary cancer, vol. 12, (no. 1), pp. 33-40.e4, 2014/Feb. | Journal Article
 
Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy.
Galsky, Matthew⋅Moshier, Erin⋅Krege, Susan⋅Lin, Chia-Chi⋅Hahn, Noah⋅Ecke, Thorsten⋅Sonpavde, Guru⋅Pond, Gregory⋅Godbold, James⋅Oh, William K and Bamias, Aristotle
Urologic oncology, vol. 32, (no. 1), pp. 48.e1-8, 2014/Jan. | Journal Article
2013
DNMT1: an emerging target in the treatment of invasive urinary bladder cancer.
Dhawan, Deepika⋅Ramos-Vara, José A⋅Hahn, Noah⋅Waddell, Jolena⋅Olbricht, Gayla R⋅Zheng, Rong⋅Stewart, Jane C and Knapp, Deborah W
Urologic oncology, vol. 31, (no. 8), pp. 1761-9, 2013/Nov. | Journal Article
 
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer.
Galsky, Matthew⋅Galsky, Matthew⋅Hahn, Noah⋅Hahn, Noah⋅Powles, Thomas⋅Powles, Thomas⋅Hellerstedt, Beth⋅Hellerstedt, Beth A⋅Lerner, Seth⋅Lerner, Seth P⋅Gardner, Thomas⋅Gardner, Thomas A⋅Yu, Menggang⋅Yu, Menggang⋅O'Rourke, Mark⋅O'Rourke, Mark⋅Vogelzang, Nicholas J⋅Vogelzang, Nicholas⋅Kocs, Darren⋅Kocs, Darren⋅McKenney, Scott⋅McKenney, Scott A⋅Melnyk, Anton⋅Melnyk, Anton M⋅Hutson, Thomas E⋅Hutson, Thomas⋅Rauch, Mary⋅Rauch, Mary⋅Wang, Yunfei⋅Wang, Yunfei⋅Asmar, Lina⋅Asmar, Lina⋅Sonpavde, Guru and Sonpavde, Guru
Clinical genitourinary cancer, vol. 11, (no. 2), pp. 175-81, 2013/Jun. | Journal Article
 
Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
Galsky, Matthew⋅Moshier, Erin⋅Krege, Susan⋅Lin, Chia-Chi⋅Hahn, Noah⋅Ecke, Thorsten⋅Sonpavde, Guru⋅Godbold, James⋅Oh, William K and Bamias, Aristotle
Cancer, vol. 119, (no. 16), pp. 3012-9, 2013/Aug/15. | Journal Article
 
Novel markers of squamous differentiation in the urinary bladder.
Huang, Wenbin⋅Williamson, Sean R⋅Rao, Qiu⋅Lopez-Beltran, Antonio⋅Montironi, Rodolfo⋅Eble, John N⋅Grignon, David J⋅Idrees, Muhammad T⋅Emerson, Robert E⋅Zhou, Xiao-Jun⋅Zhang, Shaobo⋅Baldridge, Lee A⋅Hahn, Noah⋅Wang, Mingsheng⋅Koch, Michael O and Cheng, Liang
Human pathology, vol. 44, (no. 10), pp. 1989-97, 2013/Oct. | Journal Article
 
Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy.
Galsky, Matthew⋅Krege, Susan⋅Lin, Chia-Chi⋅Hahn, Noah⋅Ecke, Thorsten⋅Moshier, Erin⋅Sonpavde, Guru⋅Godbold, James⋅Oh, William K and Bamias, Aristotle
Cancer, vol. 119, (no. 16), pp. 3020-6, 2013/Aug/15. | Journal Article
 
The impact of gender on outcomes in patients with metastatic urothelial carcinoma.
Haines, Lindsay⋅Bamias, Aristotle⋅Krege, Susan⋅Lin, Chia-Chi⋅Hahn, Noah⋅Ecke, Thorsten H⋅Moshier, Erin⋅Sonpavde, Guru⋅Godbold, James⋅Oh, William K and Galsky, Matthew D
Clinical genitourinary cancer, vol. 11, (no. 3), pp. 346-52, 2013/Sep. | Journal Article
2012
Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis
Proverbs-Singh, Tracy⋅Chiu, Sophia K⋅Liu, Ziyue⋅Seng, Sonia⋅Sonpavde, Guru⋅Choueiri, Toni⋅Tsao, Che-Kai⋅Yu, Menggang⋅Hahn, Noah M⋅Oh, William K and Galsky, Matthew
Journal of the National Cancer Institute, vol. 104, (no. 23), Dec 5, 2012. | Journal Article
 
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
Meeks, Joshua J⋅Bellmunt, Joaquim⋅Bochner, Bernard H⋅Clarke, Noel W⋅Daneshmand, Siamak⋅Galsky, Matthew⋅Hahn, Noah⋅Lerner, Seth P⋅Mason, Malcolm⋅Powles, Thomas⋅Sternberg, Cora N and Sonpavde, Guru
European urology, vol. 62, (no. 3), pp. 523-33, 2012/Sep. | Journal Article
 
Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.
Choueiri, T.K.⋅Choueiri, Toni⋅Ross, R.W.⋅Ross, Robert W⋅Jacobus, S.⋅Jacobus, Susanna⋅Vaishampayan, U.⋅Vaishampayan, Ulka⋅Yu, E.Y.⋅Yu, Evan Y⋅Quinn, David Ian⋅Quinn, D.I.⋅Hahn, Noah⋅Hahn, N.M.⋅Hutson, T.E.⋅Hutson, Thomas E⋅Sonpavde, Guru⋅Sonpavde, G.⋅Morrissey, S.C.⋅Morrissey, Stephanie C⋅Buckle, Geoffrey C⋅Buckle, G.C.⋅Kim, William Y⋅Kim, W.Y.⋅Petrylak, D.P.⋅Petrylak, Daniel P⋅Ryan, Christopher W⋅Ryan, C.W.⋅Eisenberger, Mario A⋅Eisenberger, M.A.⋅Mortazavi, Amir⋅Mortazavi, A.⋅Bubley, Glenn J⋅Bubley, G.J.⋅Taplin, M.-E.⋅Taplin, Mary-Ellen⋅Rosenberg, J.E.⋅Rosenberg, Jonathan E⋅Kantoff, P.W. and Kantoff, Philip W
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, (no. 5), pp. 507-12, 2012/Feb/10. | Journal Article
 
Novel molecular targets for the therapy of urothelial carcinoma.
Jana, Bagi R⋅Galsky, Matthew⋅Hahn, Noah⋅Milowsky, Matthew I and Sonpavde, Guru
Expert opinion on therapeutic targets, vol. 16, (no. 5), pp. 499-513, 2012/May. | Journal Article
 
Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis.
Seng, Sonia⋅Liu, Ziyue⋅Chiu, Sophia K⋅Proverbs-Singh, Tracy⋅Sonpavde, Guru⋅Choueiri, Toni⋅Tsao, Che-Kai⋅Yu, Menggang⋅Hahn, Noah⋅Oh, William K and Galsky, Matthew
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, (no. 35), pp. 4416-26, 2012/Dec/10. | Journal Article
 
Subcutaneous 5-Azacitidine Treatment of Naturally Occurring Canine Urothelial Carcinoma: A Novel Epigenetic Approach to Human Urothelial Carcinoma Drug Development
Hahn, Noah M⋅Hahn, Noah⋅Bonney, Patty L⋅Bonney, Patty⋅Dhawan, Deepika⋅Dhawan, Deepika⋅Jones, David R⋅Jones, David⋅Balch, Curtis⋅Balch, Curtis⋅Guo, Zhongmin⋅Guo, Zhongmin⋅Hartman-Frey, Corie⋅Hartman-Frey, Corie⋅Fang, Fang⋅Fang, Fang⋅Parker, Heidi G⋅Parker, Heidi⋅Kwon, Erika M⋅Kwon, Erika⋅Ostrander, Elaine A⋅Ostrander, Elaine⋅Nephew, Ken⋅Nephew, Kenneth⋅Knapp, Deborah and Knapp, Deborah W
Journal of Urology, vol. 187, (no. 1), pp. 302-309, 2012. | Journal Article
 
Successful recruitment of healthy African American men to genomic studies from high-volume community health fairs: implications for future genomic research in minority populations.
Patel, Yash R⋅Carr, Katherine A⋅Magjuka, David⋅Mohammadi, Yousef⋅Dropcho, Edward F⋅Reed, Angela D⋅Moore, Marietta L⋅Waddell, Mary J⋅Shedd-Steele, Rivienne⋅Sweeney, Christopher J and Hahn, Noah
Cancer, vol. 118, (no. 4), pp. 1075-82, 2012/Feb/15. | Journal Article
 
Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: a meta-analysis.
Sivendran, Shanthi⋅Liu, Ziyue⋅Portas, Louis J⋅Yu, Menggang⋅Hahn, Noah⋅Sonpavde, Guru⋅Oh, William K and Galsky, Matthew D
Cancer treatment reviews, vol. 38, (no. 7), pp. 919-25, 2012/Nov. | Journal Article
2011
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy.
Galsky, Matthew⋅Hahn, Noah⋅Rosenberg, Jonathan E⋅Sonpavde, Guru⋅Hutson, Thomas⋅Oh, William K⋅Dreicer, Robert⋅Vogelzang, Nicholas⋅Sternberg, Cora⋅Bajorin, Dean F and Bellmunt, Joaquim
The lancet oncology, vol. 12, (no. 3), pp. 211-4, 2011/Mar. | Journal Article
 
ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer.
Rossi, Carl J⋅Joe Hsu, I-Chow⋅Abdel-Wahab, May⋅Arterbery, V E⋅Ciezki, Jay⋅Frank, Steven J⋅Hahn, Noah⋅Moran, Brian J⋅Rosenthal, Seth A and Merrick, Gregory
American journal of clinical oncology, vol. 34, (no. 1), pp. 92-8, 2011/Feb. | Journal Article
 
American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer.
Frank, Steven J⋅Arterbery, V E⋅Hsu, I Chow J⋅Abdel-Wahab, May⋅Ciezki, Jay P⋅Hahn, Noah⋅Mohler, James L⋅Moran, Brian J⋅Rosenthal, Seth A⋅Rossi, Carl J⋅Yamada, Yoshiya and Merrick, Gregory
Brachytherapy, vol. 10, (no. 5), pp. 357-62, 2011 Sep-Oct. | Journal Article
 
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).
Harrison, Michael⋅Harrison, Michael R⋅Harrison, Michael⋅Hahn, Noah⋅Hahn, Noah⋅Hahn, Noah⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Oh, William K⋅Oh, William⋅Oh, William⋅Hammers, Hans⋅Hammers, Hans⋅Hammers, Hans⋅Sweeney, Christopher J⋅Sweeney, Christopher⋅Sweeney, Christopher⋅Kim, KyungMann⋅Kim, Kyungmann⋅Kim, KyungMann⋅Perlman, Scott⋅Perlman, Scott⋅Perlman, Scott⋅Arnott, Jamie⋅Arnott, Jamie⋅Arnott, Jamie⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Wilding, George⋅Wilding, George⋅Wilding, George⋅Liu, Glenn⋅Liu, Glenn and Liu, Glenn
Investigational new drugs, vol. 29, (no. 6), pp. 1465-74, 2011/Dec. | Journal Article
 
Epigenetics in prostate cancer.
Albany, Costantine⋅Alva, Ajjai S⋅Aparicio, Ana⋅Singal, Rakesh⋅Yellapragada, Sarvari⋅Sonpavde, Guru and Hahn, Noah M
Prostate cancer, vol. 2011, pp. 580318, 2011. | Journal Article